These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30878493)

  • 21. Fat Mass Reduction With Adipocyte Hypertrophy and Insulin Resistance in Heterozygous PPARγ Mutant Rats.
    Gumbilai V; Ebihara K; Aizawa-Abe M; Ebihara C; Zhao M; Yamamoto Y; Mashimo T; Hosoda K; Serikawa T; Nakao K
    Diabetes; 2016 Oct; 65(10):2954-65. PubMed ID: 27381370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A complicated pregnancy in a patient with lipodystrophic diabetes attributable to a peroxisome proliferator-activated receptor gamma (PPARG) mutation.
    Madhra M; Noh RM; Zammitt NN; Patrick AW; Love CD
    Diabet Med; 2012 Oct; 29(10):e398-401. PubMed ID: 22803842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
    Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone Regulates Browning and Energy Metabolism Through Mature Osteoblast/Osteocyte PPARγ Expression.
    Brun J; Berthou F; Trajkovski M; Maechler P; Foti M; Bonnet N
    Diabetes; 2017 Oct; 66(10):2541-2554. PubMed ID: 28687706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.
    Broekema MF; Massink MPG; Donato C; de Ligt J; Schaarschmidt J; Borgman A; Schooneman MG; Melchers D; Gerding MN; Houtman R; Bonvin AMJJ; Majithia AR; Monajemi H; van Haaften GW; Soeters MR; Kalkhoven E
    Mol Metab; 2019 Feb; 20():115-127. PubMed ID: 30595551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Energy balance and food intake: the role of PPARgamma gene polymorphisms.
    Cecil JE; Watt P; Palmer CN; Hetherington M
    Physiol Behav; 2006 Jun; 88(3):227-33. PubMed ID: 16777151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic Characterization of Mice Carrying Homozygous Deletion of KLF11, a Gene in Which Mutations Cause Human Neonatal and MODY VII Diabetes.
    Mathison A; Escande C; Calvo E; Seo S; White T; Salmonson A; Faubion WA; Buttar N; Iovanna J; Lomberk G; Chini EN; Urrutia R
    Endocrinology; 2015 Oct; 156(10):3581-95. PubMed ID: 26248217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mutation in the peroxisome proliferator-activated receptor gamma-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice.
    Olswang Y; Cohen H; Papo O; Cassuto H; Croniger CM; Hakimi P; Tilghman SM; Hanson RW; Reshef L
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):625-30. PubMed ID: 11792850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaempferia parviflora Ethanol Extract, a Peroxisome Proliferator-Activated Receptor γ Ligand-binding Agonist, Improves Glucose Tolerance and Suppresses Fat Accumulation in Diabetic NSY Mice.
    Ochiai M; Takeuchi T; Nozaki T; Ishihara KO; Matsuo T
    J Food Sci; 2019 Feb; 84(2):339-348. PubMed ID: 30726580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse model of conditional lipodystrophy.
    Kim S; Huang LW; Snow KJ; Ablamunits V; Hasham MG; Young TH; Paulk AC; Richardson JE; Affourtit JP; Shalom-Barak T; Bult CJ; Barak Y
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16627-32. PubMed ID: 17921248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations.
    Demir T; Onay H; Savage DB; Temeloglu E; Uzum AK; Kadioglu P; Altay C; Ozen S; Demir L; Cavdar U; Akinci B
    Diabet Med; 2016 Oct; 33(10):1445-50. PubMed ID: 26756202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An adipose tissue-independent insulin-sensitizing action of telmisartan: a study in lipodystrophic mice.
    Rong X; Li Y; Ebihara K; Zhao M; Aini W; Kusakabe T; Hirata M; Miyamoto L; Murray M; Nakao K
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1096-103. PubMed ID: 19770292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-specific peroxisome proliferator activated receptor gamma expression and metabolic effects of telmisartan.
    Zídek V; Mlejnek P; Simáková M; Silhavy J; Landa V; Kazdová L; Pravenec M; Kurtz TW
    Am J Hypertens; 2013 Jun; 26(6):829-35. PubMed ID: 23426788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover.
    Kamble PG; Pereira MJ; Gustafsson S; Lundkvist P; Castillejo-López C; Fall T; Ingelsson E; Eriksson JW
    Adipocyte; 2018; 7(4):285-296. PubMed ID: 30064293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased PPAR gamma expression compromises perigonadal-specific fat deposition and insulin sensitivity.
    Tsai YS; Tsai PJ; Jiang MJ; Chou TY; Pendse A; Kim HS; Maeda N
    Mol Endocrinol; 2009 Nov; 23(11):1787-98. PubMed ID: 19749155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance.
    Jones JR; Barrick C; Kim KA; Lindner J; Blondeau B; Fujimoto Y; Shiota M; Kesterson RA; Kahn BB; Magnuson MA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6207-12. PubMed ID: 15833818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor (PPAR) isoforms are differentially expressed in peri-implantation porcine conceptuses.
    Blitek A; Szymanska M
    Theriogenology; 2017 Oct; 101():53-61. PubMed ID: 28708516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central players in inherited lipodystrophies.
    Jeninga EH; Kalkhoven E
    Trends Endocrinol Metab; 2010 Oct; 21(10):581-8. PubMed ID: 20621503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.
    Monajemi H; Zhang L; Li G; Jeninga EH; Cao H; Maas M; Brouwer CB; Kalkhoven E; Stroes E; Hegele RA; Leff T
    J Clin Endocrinol Metab; 2007 May; 92(5):1606-12. PubMed ID: 17299075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy.
    Gosseaume C; Fournier T; Jéru I; Vignaud ML; Missotte I; Archambeaud F; Debussche X; Droumaguet C; Fève B; Grillot S; Guerci B; Hieronimus S; Horsmans Y; Nobécourt E; Pienkowski C; Poitou C; Thissen JP; Lascols O; Degrelle S; Tsatsaris V; Vigouroux C; Vatier C
    Eur J Endocrinol; 2023 Mar; 188(3):. PubMed ID: 36806620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.